Related Experiment Video
Updated: Jul 1, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
O-GlcNAcylation of FOXK1 orchestrates the E2F pathway and promotes oncogenesis
Louis Masclef1, Oumaima Ahmed1, Nicholas Iannantuono2
1Centre de recherche de l'Hôpital Maisonneuve-Rosemont, CIUSSS de l'Est-de-l'Île de Montréal, 5415 boulevard de l'Assomption, Montréal, QC, H1T 2M4, Canada.
Abstract:
Gene transcription is a highly regulated process, and deregulation of transcription factors activity underlies numerous pathologies including cancer. Albeit near four decades of studies have established that the E2F pathway is a core transcriptional network that govern cell division in multi-cellular organisms1,2, the molecular mechanisms that underlie the functions of E2F transcription factors remain incompletely understood. FOXK1 and FOXK2 transcription factors have recently emerged as important regulators of cell metabolism, autophagy and cell differentiation3-6. While both FOXK1 and FOXK2 interact with the histone H2AK119ub deubiquitinase BAP1 and possess many overlapping functions in normal biology, their specific functions as well as deregulation of their transcriptional activity in cancer is less clear and sometimes contradictory7-13. Here, we show that elevated expression of FOXK1, but not FOXK2, in primary normal cells promotes transcription of E2F target genes associated with increased proliferation and delayed entry into cellular senescence. FOXK1 expressing cells are highly prone to cellular transformation revealing important oncogenic properties of FOXK1 in tumor initiation. High expression of FOXK1 in patient tumors is also highly correlated with E2F gene expression. Mechanistically, we demonstrate that FOXK1, but not FOXK2, is specifically modified by O-GlcNAcylation. FOXK1 O-GlcNAcylation is modulated during the cell cycle with the highest levels occurring during the time of E2F pathway activation at G1/S. Moreover, loss of FOXK1 O-GlcNAcylation impairs FOXK1 ability to promote cell proliferation, cellular transformation and tumor growth. Mechanistically, expression of FOXK1 O-GlcNAcylation-defective mutants results in reduced recruitment of BAP1 to gene regulatory regions. This event is associated with a concomitant increase in the levels of histone H2AK119ub and a decrease in the levels of H3K4me1, resulting in a transcriptional repressive chromatin environment. Our results define an essential role of O-GlcNAcylation in modulating the functions of FOXK1 in controlling the cell cycle of normal and cancer cells through orchestration of the E2F pathway.
Insights
Forkhead box K1 (FOXK1) promotes cell proliferation and tumor initiation by regulating the E2F pathway. O-GlcNAcylation of FOXK1 is crucial for its oncogenic functions and interaction with BAP1, impacting cell cycle control.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Gene transcription regulation is vital, with E2F pathway controlling cell division.
- Dysregulation of transcription factors, including FOXK1 and FOXK2, contributes to cancer.
- Specific roles of FOXK1 and FOXK2 in cancer and their interaction with BAP1 are not fully understood.
Purpose of the Study:
- To investigate the distinct roles of FOXK1 and FOXK2 in regulating the E2F pathway and cell cycle.
- To elucidate the mechanisms by which FOXK1 contributes to cellular transformation and tumor initiation.
- To determine the impact of FOXK1 post-translational modifications, specifically O-GlcNAcylation, on its function.
Main Methods:
- Analysis of FOXK1 and FOXK2 expression in normal cells and patient tumors.
- Cell proliferation and senescence assays.
- Cellular transformation and tumor growth studies.
- Investigation of FOXK1 O-GlcNAcylation and its cell cycle-dependent regulation.
- Chromatin immunoprecipitation to assess BAP1 recruitment and histone modifications.
Main Results:
- Elevated FOXK1 expression, unlike FOXK2, enhances E2F target gene transcription, promoting proliferation and delaying senescence.
- FOXK1 exhibits oncogenic properties, driving cellular transformation and tumor initiation.
- FOXK1, but not FOXK2, is O-GlcNAcylated in a cell cycle-dependent manner, peaking at G1/S.
- Impaired FOXK1 O-GlcNAcylation reduces its ability to promote proliferation, transformation, and tumor growth.
- O-GlcNAcylation-defective FOXK1 mutants show reduced BAP1 recruitment, increased H2AK119ub, and decreased H3K4me1, creating a repressive chromatin state.
Conclusions:
- FOXK1 plays a critical role in promoting cell proliferation and tumor initiation through the E2F pathway.
- O-GlcNAcylation is essential for FOXK1 function, regulating its interaction with BAP1 and chromatin remodeling.
- These findings highlight FOXK1 O-GlcNAcylation as a key mechanism controlling the cell cycle in normal and cancer cells.
More Related Videos
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Induced Pluripotent Stem Cells
Somatic...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle